Çok Damar Hastalığı Görüntüleme - Murat Sezer

5/19/2018 ok Damar Hastal Grntleme - Murat Sezer

1/35

!"# %&'&( )&*+&,-.-/%& 01(121'%3 )&/01*14

5/&+"'1 6789:; ?

@(A BC(&+ :3D3(

E1DF","G1 6 EEH; 1EH ?


2/35

5/G1F"0(&I# J"# %&'&( )&*+&,-.-

K&/01 ,3DF"/,&( 1*#3'1#; )&/01 ,3DF"/L,&( /&*-, 6*+3/+ J&MLN"F? (3O&*#C,&(1D3 3%1,'3,14


3/35

EEH

"#$%&'()%*+,%&-./ +01-%23/%4)#,-./5/ +&'#6+' 7.8%/&+-#)+/#9

'%*%* $#*++)6#&+

789: "#$%&'()%*+,%&-./5/ 7)%/)%/6%&3:

.716+,%&-./5

;*%*.6>% ?.' >%6%*

0%&8%)3@3 $%*)3@3/>% &.*56)5 )#,-./A)#,-./)%*3/ B#)+*)#/6#&+

C8#/8# $%&'5)#* -%/38D

!"# %&'&( )&*+&,-.-/%& 1/O&*1P 1/+("("/3( +&/-*&, FQ/+3',3(

EFGH ICJAI;JKC L5+>#)+/#& ./

6-.2%*>+%) *#$%&25)%*+,%1./


4/35

!"# %&'&( )&*+&,-.-/%& 1/O&*1P 1/+("("/3( +&/-*&, FQ/+3',3(


5/35

EEH; 1EH "#$%&'()%*+,%&-./ +01-%23/% 4)#,-./5/

+&'#6+' 7.8%/&+-#)+/#9 '%*%* $#*++)6#&+

789: "#$%&'()%*+,%&-./5/ 7)%/)%/6%&3: .716+,%&-./5

;*%*.6>% ?.' >%6%* 0%&8%)3@3$%*)3@3/>% &.*56)5 )#,-./A)#,-./)%*3/ B#)+*)#/6#&+

C8#/8# $%&'5)#* -%/38D

!"# %&'&( )&*+&,-.-/%& 1/O&*1P 1/+("("/3( +&/-*&, FQ/+3',3(


6/35

EEH

!5S7T7

TANIM

M N.' >%6%* 0%&8%)3@3 %/O+-.P*%Q' .)%*%'

63 R./'&+-./#) .)%*%' 63 8%/36)%/6%)3D

M ;/O+-.P*%Q' ?.' >%6%* 0%&8%)3@3 S T>%6%*>% S UVF >%*)3' B5)5/6%&3

M W;XIY># %/O+-.P*%Q' .)%*%' T >%6%*.)%/ 0%&8%)%*3/ %/2%' UGHY (R./'&+-./#) .)%*%' T >%6%*Z

[U

THU

HTU

UVW

X %&'&( )&*+&,-.-4

F >%6%*

G >%6%*

E >%6%*

T >%6%*


7/35

EEH

!5S7T7 1329 lezyon!

FFR - klavuzlu!u kolunda

\VU EFU HU

5/GA %&(,-#


8/35

HFFF .*8% >#*#2#)+ '.*./#*>%*)3@3/ >#@#*)#/>+*+)6#&+/>#

%/%8.6+' AR./'&+-./#) >+&'.*>%/&]

^%*)3')%*3/ -%')%%/& P_&8#*+-.*Z

5/&+"'1# L IDF","G1# %1*#"(%&/*

EEH


9/35

5/&+"'1# L IDF","G1# %1*#"(%&/*

U V\WW" ` FZaF

WVVEEHZ[A\

;/O+-.P*%Q' >%*)+' ZUbV

WW" ` FZaF

WW" S FZaF

UEH

Ub\

;/O+-.P*%Q' >%*)+' ]UbV

"#$#* 6+&6%820 ] c*+6#* 7*#>+'8_*!"# %&'&( )&*+&,-.-

5/G1F"0(&I# ",&( "(+& %3(3^3%3 ",%C.C %_2_/_,3/ X``\ %&(,-#+& P"/#*1F"/3, %3.3(,3/%1('3


10/35

5abcd#2# +/R#*+.*+&'#6+

"J;Y-% P+*+#*+)6+%6%* 0%&8%)3@3$%*)3@3/>% %/% '.*./#* 0%&8%)3@3/3/WW" +)# >#@#*)#/>+*+)6#&+ 7*.B)#6%1':

^+&8%) )#,-./)%*3/ 4*+ $#-%7%*%)#) 9 '.*./#* )#,-./5/5/0#6.>+/%6+' #8'+&+/+/5/>#*#&16%8# #>+)6#&+/# B#7.)5*?


14/35

`A h5H5SiS Sijd% %,%)6%

Jf; &8#/8

B1F"#&(% 6 khl V ` ?

m/^3 21%%3+,1 %&(,-# &J-,'&,-

EEH CF0C,&'&*-/-/ M("N,3'&f# ",%C.C %C(C',&(g


15/35

XA >5a@iB L :iHc Sijd

0.64

0.72

0.16 0.20

0.28

^+&8%) )#,-./ 7*.'&+6%) )#,-./ &./*%&3 %'363 %,%)8%*%' 7*.'&+6%) )#,-./5/ WW"Y3/>% .$#*#&16%&-./% -.) %?%*Z

g/2# >+&8%) )#,-./ 8#>%$+ #>+)6#)+

GZ e#,-./ &./*%&30+7#*#6+' %'36>%

*#&1*+'&+-./

;'36>% *B#&803,)%/6%

6 khl V ` ?

ch

c6

c>

WW"4;9 i c> j 4c6Ac%9ck

c%lc6 m c>lck

WW"4n9 i 4c%lck9 4c6 j c>9c% 4c6 j ck9

;

n

c%

EEH CF0C,&'&*-/-/ M("N,3'&f# ",%C.C %C(C',&(g


16/35

VA RiH5Scj5:d3/: >+-%B#1': #R.* %/P+/%&3 4m9: CcIJK ] d/R#*+-.* m %/8#*+-.* +&'#6+

e;^ "J; '.))%8#*%))#*

EEH CF0C,&'&*-/-/ M("N,3'&f# ",%C.C %C(C',&(g


17/35

nA RiH5Scj5:d


18/35

Anjiyografik >2

damar hastal

FFR


19/35

[ZV

\ZG

F

G

E

T

H

V

\b

a

[

GF

;/O+-.P*RZ o3)%$Z"#$%&'Z

W./'Z 4WW"9 "#$%&'Z

ci FZFT

U

lm ve Miyokard nfarkts -2 yl

E5Bi


20/35

=5o

Va

bG

ba

VF

b\

aE

F

GF

EFTF

HF

VF

\F

bF

aF

[F

Jpq";LI CrsK;f W;XI

;/O+-.coL

;/O+-.coL

;/O+-.

coL

WW"coL

n-l7%&&

X#>+'%)

G -3)>% U %/O+/%&3,)3'U


21/35

EGZV

GaZ\GbZE

GVZa

aZaGFZG

GHZb

GG

F

V

GF

GV

EF

EV

C-/8%t: TAT C-/8%t: EAT C-/8%t: GAT W;XI

WW"coL

1 Ylda Major Kardiyak Olay skl

, SYNTAX

3damar

/ FAME

:da>5o X %&'&( p E5Bi

coL coLcoLo;nJ o;nJo;nJ


22/35

G[ZGF GaZH

GGZE

GTZE

FZFF

VZFF

GFZFF

GVZFF

EFZFF

EVZFF

CrsK;f W;XI:da>5o E5Bi

coL n-l7%&&

;/O+-.coL WW"coL

U d-, B5=i

X;JJIU

:da>5o p E5Bi


23/35

EGG[ZG

GVZa

Ea

GGZE GG

F

V

GF

GV

EF

EV

TF

G E T

X#>Z coL coL o;nJ ;/PZ WW"

p)>*.-> oL: I5*. d/8#*$ZZ EFF[uV 4G9]\Tl\\

MACCE = nme +), enzimatik MI -)

:da>5o X %&'&( p E5Bi


24/35

UTH

UTH

UTE

C-/8%t GAT C-/8%t EAT

C-/8%t TAT

UV[UEG

UEF

C-/8%t GAT C-/8%t EAT

C-/8%t TAT

;/O+-.P*%Q' C-/8%t W./'&+-./#) C-/8%t

WX` v%&8% >%0% >(


25/35

m,_'; B7; H3O&*#C,&(1D&*F"/ m,_'; B7

Fonksiyonel Anjiyografik Syntax


26/35

EEH; 1EH "#$%&'()%*+,%&-./ +01-%23/%

4)#,-./5/ +&'#6+' 7.8%/&+-#)+/#9

'%*%* $#*++)6#&+

789: "#$%&'()%*+,%&-./5/ 7)%/)%/6%&3:

.716+,%&-./5

;*%*.6>% ?.' >%6%*

0%&8%)3@3 $%*)3@3/>% &.*56)5 )#,-./A)#,-./)%*3/ B#)+*)#/6#&+

C8#/8# $%&'5)#* -%/38D

789: p


27/35

dxqC] P+*+%6%*0%&8%)3@3/>% B+R5*'%&-./P+*+


28/35

dxqC] P+*+%6%*0%&8%)3@3/>% B+R5*'%&-./P+*+% B+R5*'%&-./ P+*++.)ZEFGF


29/35

dxqC] P+*+%6%*0%&8%)3@3/>% B+R5*'%&-./P+*+# W`s %,%)6%

y0%/P #8 %)Z I5*.+/8#*$#/1./ EFGH


30/35

dxqC] P+*+%6%*0%&8%)3@3/>% B+R5*'%&-./ P+*+ t @i:

I/ B(-(' dxqC ?%)3% T >%6%* 0%&8%)3@3

dxqC '5))%/363 _/#6)+

7*.>5*%) R%*' -%*%=-.*Z

h+8,#/B+20)#* #8 %)ZJ+*25)%1./ EFGH


31/35

dxqC] P+*+%6%* 0%&8%)3@3/>%B+R5*'%&-./ P+*+ t @i:

aVbV 0%&8% ^IC l dxqC UTF 0%&8%>% T >%6%* 0%&8%)3@3

C8#/8 8*.6B.,5 $# X;JIY># 4CKm'%*>+-%' _)(6 $# Xd9 %/)%6)3%,%)6%

h+8,#/B+20)#* #8 %)ZJ+*25)%1./ EFGH


32/35

R,1/1# CF0C,&'&% 6hRe? F3(1

coLY># pJKY/+/ -#*+

r%')%% coLY># ')+/+' -%*%* 8#'?%)3% %/2%' ;oC 0%&8%)%*3/>%P_&8#*+)6+< >5*56>%Z9 Xx^ 7.7()%&-./5UGVY)#* 2+$%*3/>%9Z

{Y^pJKp"CYY] sCKI;oCY^; .28'3)%$5,)5@5/>% coLY/+/ ')+/+' &./)%/36)%*%#8'+&+ %*%


33/35

:da>5o 77


34/35

!5S7T7 64?


35/35

!5S7T7g

Documents

Çok Damar Hastalığı Görüntüleme - Murat Sezer